Additional file 1 of Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review

Abstract

Additional file 1: Table S1. Assessment of quality of the included observational studies (Newcastle–Ottawa Quality Assessment Scale). Table S2. Collection methods of adverse events and the frequencies of specific adverse events in the included studies. Table S3. Testing methods of anti-SARS-CoV-2 IgG, Neutralizing Antibodies, and cellular immunity in the included studie